Sensus Healthcare Inc (SRTS)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Joseph C. Sardano
Employees:
40
851 BROKEN SOUND PARKWAY NW, SUITE 215, BOCA RATON, FL 33487
561-922-5808

Sensus Healthcare, Inc. manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. SRT-100 is an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers.

Data derived from most recent annual or quarterly report
Market Cap 83.559 Million Shares Outstanding16.612 Million Avg 30-day Volume 236.065 Thousand
P/E Ratio7.7782 Dividend Yield0.0 EPS0.11
Price to Revenue4.6777 Debt to Equity0.0 EBITDA16.362 Million
Price to Book Value4.4125 Operating Margin35.9481 Enterprise Value170.359 Million
Current Ratio7.827 EPS Growth82 Quick Ratio6.831
1 Yr BETA 1.0528 52-week High/Low 15.25 / 4.8 Profit Margin60.1377
Operating Cash Flow Growth510.3175 Altman Z-Score19.1893 Free Cash Flow to Firm 10.754 Million
Earnings Report2023-05-04
View SEC Filings from SRTS instead.

View recent insider trading info

Funds Holding SRTS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SRTS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-02-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-09:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-03-09:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-05:
    Item 9.01: Financial Statements and Exhibits
    Item 2.02: Results of Operations and Financial Condition
  • Proposed Sales (Form 144)

    Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    RAMPOLLA JAVIER CHIEF FINANCIAL OFFICER

    • Officer
    48,114 2023-02-01 2

    SARDANO MICHAEL PRESIDENT AND GENERAL COUNSEL

    • Officer
    55,774 2023-01-26 3

    MARTINEZ MAGDALENA CHIEF OPERATING OFFICER

    • Officer
    18,000 2023-01-03 1

    SOSA EMILIANO CHIEF TECHNOLOGY OFFICER

    • Officer
    10,000 2023-01-03 1

    SARDANO JOSEPH C CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    1,130,293 2022-09-02 2

    O'REAR SAMUEL

    • Director
    123,570 2022-08-09 1

    MCCALL WILLIAM H

    • Director
    325,723 2022-05-10 1

    SORO NICOLAS CHIEF OPERATING OFFICER

    • Officer
    3,546 2022-03-09 0

    COHEN STEPHEN BRAD EXECUTIVE VICE PRESIDENT

    • Officer
    830,585 2021-12-15 0

    PETRELLI ANTHONY BENEDICT

    • Director
    46,466 2021-07-21 0

    HEINRICH JOHN

    • Director
    69,940 2021-07-21 0

    CORNISH MEGAN

    • Director
    12,000 2021-07-21 0

    VAINER YONATAN CHIEF TECHNOLOGY OFFICER

    • Officer
    5,000 2021-01-01 0

    PRICE RUSS CHIEF TECHNOLOGY OFFICER

    • Officer
    6,814 2020-01-06 0

    LEVINE ARTHUR CHIEF FINANCIAL OFFICER

    • Officer
    186,709 2019-06-02 0

    FISHMAN KALMAN CHIEF TECHNOLOGY OFFICER

    • Officer
    931,007 2019-03-22 0

    GOLIN RICHARD EXECUTIVE VICE PRESIDENT

    • Officer
    924,236 2019-03-20 0

    RIGEL DARRELL S

    • Director
    0 2016-06-08 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    RAMPOLLA JAVIER - Officer CHIEF FINANCIAL OFFICER

    2023-02-03 14:19:29 -0500 2023-02-01 F 742 $8.84 d 48,114 direct -0.1133 -20.2718 -41.9026 2.6048 3 -42.1291 30

    SARDANO MICHAEL - Officer PRESIDENT AND GENERAL COUNSEL

    2023-02-01 11:44:50 -0500 2023-01-26 F 3,745 $8.96 d 55,774 direct 3.0543 0.4525 -41.0633 3.0543 2 -41.0633 31

    SARDANO MICHAEL - Officer PRESIDENT AND GENERAL COUNSEL

    2023-02-01 11:44:50 -0500 2023-01-26 A 10,000 a 59,519 direct 3.0543 0.4525 -41.0633 3.0543 2 -41.0633 31

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SENSUS HEALTHCARE INC SRTS 2023-03-24 22:15:03 UTC 4.361 0.459 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 21:45:03 UTC 4.361 0.459 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 21:15:03 UTC 4.361 0.459 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 20:45:03 UTC 4.361 0.459 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 20:15:04 UTC 4.361 0.459 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 19:45:03 UTC 4.361 0.459 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 19:15:04 UTC 4.361 0.459 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 18:45:04 UTC 4.3591 0.4609 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 18:15:03 UTC 4.3591 0.4609 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 17:45:03 UTC 4.3591 0.4609 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 17:15:03 UTC 4.3591 0.4609 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 16:45:03 UTC 4.3565 0.4635 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 16:15:03 UTC 4.3565 0.4635 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 15:45:03 UTC 4.3565 0.4635 450000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 15:15:03 UTC 4.3565 0.4635 1300000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 14:45:03 UTC 4.3565 0.4635 1300000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 14:15:03 UTC 4.3565 0.4635 1300000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 13:45:03 UTC 4.121 0.449 1300000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 13:15:04 UTC 4.121 0.449 1300000
    SENSUS HEALTHCARE INC SRTS 2023-03-24 12:45:03 UTC 4.121 0.449 1300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments